Ironwood Pharmaceuticals IRWD Net interest and investment income (loss)
Net interest and investment income (loss) at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's net interest and investment income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's net interest and investment income (loss)?
- Ironwood Pharmaceuticals (IRWD) reported net interest and investment income (loss) of $1.7M in Q1 2026.
- How has Ironwood Pharmaceuticals's net interest and investment income (loss) changed year-over-year?
- Ironwood Pharmaceuticals's net interest and investment income (loss) increased by 95.4% year-over-year, from $869K to $1.7M.
- What is the long-term trend for Ironwood Pharmaceuticals's net interest and investment income (loss)?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's net interest and investment income (loss) has grown at a 53.9% compound annual growth rate (CAGR), from $726K to $4.08M.